We focused on the effectiveness and safety of coenzyme Q10 as a treatment for patients dealing with ischemic heart disease and stable angina, specifically those at class II-III levels. Over the course of eight weeks, participants took a daily dosage of 60 mg of coenzyme Q10 alongside their standard treatment regimen.
The results were promising; we observed that patients reported significant improvements in their clinical status related to angina symptoms. Importantly, this improvement occurred without any major side effects, indicating that coenzyme Q10 could be a beneficial addition to the treatment plan for those living with this condition.
However, it is essential to note that since coenzyme Q10 was used in conjunction with standard treatments, it is challenging to pinpoint its isolated effects conclusively. Future studies could help clarify how well coenzyme Q10 works on its own, but for now, the findings suggest it may be a valuable component of therapy for angina.